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Methods to promote equity in health
resource allocation in low- and middle-
income countries: an overview
James Love-Koh1* , Susan Griffin1, Edward Kataika2, Paul Revill1, Sibusiso Sibandze2 and Simon Walker1
Abstract
Unfair differences in healthcare access, utilisation, quality or health outcomes exist between and within countries
around the world. Improving health equity is a stated objective for many governments and international organizations.
We provide an overview of the major tools that have been developed to measure, evaluate and promote health
equity, along with the data required to operationalise them.
Methods are organised into four key policy questions facing decision-makers: (i) what is the current level of inequity in
health; (ii) does government health expenditure benefit the worst-off; (iii) can government health expenditure more
effectively promote equity; and (iv) which interventions provide the best value for money in reducing inequity.
Benefit incidence analysis can be used to estimate the distribution of current public health sector expenditure, with
geographical resource allocation formulae and health system reform being the main government policy levers for
improving equity. Techniques from the economic evaluation literature, such as extended and distributional cost-
effectiveness analysis can be used to identify ‘best buy’ interventions from a health equity perspective. A range of
inequality metrics, from gap measures and slope indices to concentration indices and regression analysis, can be
applied to these approaches to evaluate changes in equity.
Methods from the economics literature can provide policymakers with a toolkit for addressing multiple aspects of
health equity, from outcomes to financial protection, and can be adapted to accommodate data commonly available
in low- and middle-income settings.
Keywords: Health equity, Health inequalities, Resource allocation, Economic evaluation, Benefit incidence analysis
Introduction
Improving health equity is a key objective for many govern-
ments and international organizations [1]. Despite substan-
tial improvements to health system performance in recent
decades [2], empirical analyses of health equity have found
that inequalities have persisted between and within
countries, many of which were described by Marmot and
colleagues in their landmark report on global inequalities in
2008 [3]. Victora and colleagues, in a study of 35 low- and
middle-income countries (LMICs) found that coverage of
skilled birth attendance was more than twice as high in the
richest fifth of societies compared to the poorest fifth on
average [4]. Wagstaff and colleagues, meanwhile, analysed
64 LMICs over the period 1990–2011 and found that
socioeconomic inequalities in health status increased in
over half of the countries [5].
Health inequity can be defined as the differences in
healthcare access or utilisation, quality of care or health
outcomes that are considered avoidable and unfair, such as
those associated with socioeconomic status, ethnicity or
geographical region. An extensive literature has explored
how these inequities are determined socially through fac-
tors including income, education and employment [3, 6].
They can be further caused or compounded by the relative
under-utilisation of health services by the worst-off and
least healthy, a phenomenon known as the inverse care law
[7]. Socioeconomically advantaged groups are often better
placed to access healthcare services, can afford higher qual-
ity services when they do access care and adopt new effect-
ive services earlier than those in disadvantaged groups [8].
This means that without targeted implementation, new
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interventions and policies can inadvertently increase inequi-
ties in the population [9].
In order to assist governments and policymakers in
making equitable health resource allocation decisions, a
range of quantitative methods can be used to measure
and analyse health equity. The objective of this paper is
to provide an introductory overview of approaches, dis-
cuss their utility and limitations and provide examples of
their application.
Overview
Inequality is usually present whichever way a population is
divided. However, inequalities are only considered inequit-
able if they are unfair and avoidable. For example, higher
utilisation in low income groups might be fair when their
health needs are also greater. Conversely, part of the differ-
ence in life expectancy could be regarded as unfair if it is a
function of factors or characteristics outside of individual
control, such as ethnicity. Deciding whether differences can
be considered inequitable therefore requires value judge-
ments about the sources of inequality and will vary accord-
ing to ethical, political or cultural principles.
In this overview our focus is on the set of economic tech-
niques that can be used for whatever set of value judge-
ments are used by a decision-maker, and hereafter discuss
differences in terms of inequalities rather inequities. For a
wider discussion of the issues around value judgements in
health equity, see Kawachi et al. [10] and Sen [11]. Frame-
works for adjusting inequalities based on fairness judge-
ments are provided by Fleurbaey and Schokkaert [12].
In this paper we review a set of methods that can in-
corporate equity concerns into health resource allocation
decisions. Whilst equity remains a common priority for
health systems in LMICs, evidence on the equity impacts
of policies is often scarce [13]. The methods are orga-
nised according to four broad policy questions that they
can be useful in addressing:
(i) What is the current level of health inequality?
(ii) Does government health expenditure benefit the
worst-off?
(iii)Can government health expenditure more
effectively address inequality?
(iv)Which interventions provide the best value for
money in addressing inequality?
Questions (i) and (ii) primarily relate to issues of
inequality measurement: identifying existing inequalities
in the health system such as unequal access, utilisation
or ill-health. The techniques relevant to questions (iii)
and (iv) can be broadly referred to as policy tools: ap-
proaches that can be used to inform actions that address
existing inequalities through the allocation of resources.
What is the current level of inequality?
Quantitative analyses of health inequality use data on
healthcare utilisation and costs and health outcomes. As
equity is often defined in terms of fairness between so-
cial groups, measuring it requires information on demo-
graphic and socioeconomic variables such as area of
residence, age, sex, income or education level. Incorpor-
ating a greater number of variables allows analysts to in-
vestigate more nuanced aspects of inequality that affect
specific subgroups in society (e.g. women with low edu-
cation) [14]. The level of inequality can then be esti-
mated using a wide range of metrics that vary
considerably in their sophistication.
Gap measures
Suppose that we have data on health care utilisation
(number of visits to a local health clinic), and household
assets of a large sample of randomly selected individuals
in a population. A simple way to summarise equity
might be to take the average level of utilisation in sub-
groups defined by the level of household assets (for ex-
ample, by quintiles from the lowest to the poorest
households). From this we can calculate the absolute gap
(e.g. an average difference of 1.6 visits between the low-
est and highest income groups) or relative gap (e.g. a
180% difference in average visits). However, focusing on
the gap between the best and worst off ignores informa-
tion on the link between socioeconomic status and
healthcare use from the middle groups.
Regression-based measures
An alternative approach is to plot healthcare utilisation
against household assets, and to fit a line that predicts
how utilisation changes with wealth. The slope of this line
can be interpreted as the difference in utilisation when
moving from the bottom to the top of household asset dis-
tribution and is referred to as the slope index of inequality
[15]. An example of this is shown in Fig. 1 (left panel). If
the relationship between household assets and utilisation
is roughly linear, the slope index will be close to the abso-
lute gap. The relative inequality index can be derived from
the slope index by dividing through by mean utilisation;
this gives the percentage change in utilisation when mov-
ing from the bottom to the top of the distribution.
With more than two variables methods such as multi-
variate regression analysis can be used to estimate the
associations between social characteristics and health-
related outcomes. These can incorporate multiple equity-
relevant characteristics and control variables. The results
can be used to ‘decompose’ observed inequality – i.e. to
derive the proportion of inequality that is attributable to
different characteristics of interest. Charasse-Pouélé and
Fournier [78], for example, find that between 57 and
76% of the observed differences in health between ethnic
Love-Koh et al. Globalization and Health            (2020) 16:6 Page 2 of 12
groups in South Africa can be explained by their under-
lying socioeconomic profile.
Lorenz and concentration curves
Other metrics are more mathematically complex but can
incorporate more information than group averages, provid-
ing a richer and more informative measure of inequity.
Amongst the most commonly employed of these are the
Lorenz curve and the concentration curve. Both these
curves illustrate an observed distribution of a health vari-
able against a diagonal line representing a perfectly equal
distribution [16]. The distinction between them is the
choice of population ranking variables (represented on the
x-axis). When the population is ranked according to the
level of the health variable itself, a Lorenz curve is produced
that displays univariate inequality in health (i.e. cumulative
health against health ranking). When the population is
ranked according to a different, non-health variable (for ex-
ample, level of household assets), a concentration curve that
summarises bivariate inequality is generated. In the ex-
ample shown in the right panel of Fig. 1, individuals are
ranked in terms of their income. Income rank is then plot-
ted against the cumulative proportion of health care utilisa-
tion. For instance, the bottom 20% of the sample account
for 11.4% of overall utilisation, whilst the top 20% account
for 27%.
The Lorenz and concentration curves can be used to
calculate indices that summarise the level of inequality.
The Gini coefficient, widely used in the measurement of
income inequality, is derived from the Lorenz curve and
ranges from 0 (perfect equality – health is shared equally)
to 1 (perfect inequality - where one group holds all of the
health variable and the remainder have none). The
concentration index ranges from − 1 (perfect pro-poor
inequality – where the poorest group hold all of the health
variable) to 1 (perfect pro-rich inequality – where the
richest group hold all of the health variable), with 0 simi-
larly representing perfect equality. The concentration
index for the pro-rich distribution in the right panel of
Fig. 1 is 0.40. The Wagstaff index [17] and Erreygers index
[18] have been proposed as alternatives to the concentra-
tion index when the health variable has upper and lower
limits (e.g. vaccination coverage rates).
Measures incorporating inequality aversion
Deriving a single index measure of inequality re-
quires the specification of a set of weights attached
to each individual or population group. These
weights are then combined with the respective health
variable value and summed up to produce the index
score. The relative weights attached to individuals in
the Gini and concentration indices are (i) embedded
in the functional form of the index and (ii) derived
from the individual’s rank. The extended concentra-
tion index allows for the functional form and the
weights to be adjusted by incorporating an additional
parameter, denoted υ, that defines the degree of in-
equality aversion [19]. Inequality aversion captures
how much we care about reducing inequality: it can
be set to a level that it produces the same weights as
in the (unextended) standard concentration index (υ
=2), or such that inequalities do not matter (υ =1,
where the concentration index is always equal to
zero no matter the level of inequality). As υ increases
above 1, greater weight is applied to those with low
ranking, while the proportion of high-ranking indi-
viduals with a weight approaching zero increases.
Fig. 1 Visualizations of inequality metrics. The left panel shows the line fitted through a cloud of data to generate a slope index of inequality estimate
(1.38). The right panel shows the concentration curve of health care utilization. In both instances, low income groups use less health care than high
income groups. Notes: 1. The interpretation of the slope index is that expected utilisation increases by 1.38 units as we move from the lowest to
highest income group. 2. The concentration index is defined as two times the area between the concentration curve and the line of equality. The
former becomes more convex as inequality increases, increasing the area and the concentration index
Love-Koh et al. Globalization and Health            (2020) 16:6 Page 3 of 12
The Atkinson [20] and Kolm [21] inequality indices
also incorporate inequality aversion parameters into
their formulae. However, both weight individuals in a
distribution according to their level of health, rather
than their rank in the population. Provided there is some
degree of inequality aversion (i.e. that the parameters are
greater than zero), improvements to those at the bottom
of the distribution are valued more highly. The Atkinson
measures the degree of relative inequality, whilst the
Kolm measures the absolute difference.
Health-related social welfare
Several of the inequality measures described above can be
combined with average levels of health to provide a meas-
ure of health-related social welfare. The general form of
these functions is w = μ(1 − I), where w is the measure of
welfare, μ is the mean of the health-related variable and I
is the inequality measure. A higher value of I (greater
inequality) will therefore reduce health-related social
welfare. The extended concentration index can be used to
calculate the health achievement index [22], whilst the At-
kinson and Kolm inequality indices are used to calculate
their respective welfare indices [20, 21].
By simultaneously incorporating inequality concerns,
average gains and inequality impacts, health-related social
welfare functions can evaluate policies that include trade-
offs between inequality and average health impacts (i.e.
where both inequality between groups and average popu-
lation health increases or where both reduce). The use of
these measures requires the specification of the inequality
aversion parameter. Whilst experimental methods can be
used to elicit values for this parameter [23], sensitivity and
threshold analysis can illustrate the critical values for a
range of value judgements about inequality.
Does government health expenditure benefit the
worst-off?
Benefit incidence analysis
Inequalities in the distribution of government health
expenditures can be measured using benefit incidence
analysis (BIA). ‘Benefits’ in BIA refers not to the improve-
ments in health received by individuals but the financial
value of the services they use. For each individual, these
are calculated by multiplying the number of times each
type of health service is utilised by the respective unit cost.
Unit costs are typically estimated from national accounts,
with utilisation measured from regional health surveys.
User fees, in terms of both insurance premiums and out-
of-pocket costs, are then subtracted to calculate the
amount of public benefit received.
BIA is a technique that has been regularly used by the
World Bank and others since the 1990s to answer the
question of how public healthcare expenditures are shared
between social groups [24–28]. It consists of calculating
the share of benefits received by individuals or groups
(typically socioeconomic groups) from public health ex-
penditures, as shown in the left column of Fig. 2. Inequal-
ities are then analysed by calculating a concentration
index. A step-by-step guide to conducting BIAs can found
in McIntyre and Ataguba [29].
The data requirements for conducting a BIA include
representative information on utilisation by service
type (e.g. primary or secondary care) over a fixed
period of time and private expenditures for the popu-
lation of interest. Including a wider range of services
will lead to a more accurate picture of inequality as the
analysis can then incorporate more detailed variations
in service use; this is, however, governed by the detail
provided in national health expenditure accounts,
which vary from country to country. Another key
Fig. 2 Comparison between the distribution of benefit incidence (left column) and ill health (right column). This shows an inequitable situation in
which the lowest socioeconomic groups have the greater health needs but receive lower levels of public health service benefit. Note:
SES = socioeconomic status
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assumption is that the cost of a unit of utilisation is in-
dependent of the private user fee – in other words,
that the service received is identical regardless of how
much an individual pays. However, services with user
fees attached may be more comprehensive than fully
subsidized ones, resulting in higher unit costs. An ex-
tension to the standard BIA framework that relaxes
this assumption has been proposed by Wagstaff [30].
Evidence on the distribution of public health system
benefits does not, however, provide sufficient informa-
tion to determine how equitable the system is. In order
to do this, we also need to know the health care needs
of individuals and/or groups. This distribution of need,
represented in the right bar in Fig. 2, can be calculated
using a variety of metrics. These can be responsive to
available data, from simple health survey questionnaire
responses on self-assessed health to measures of total
disease burden. The latter quantifies all health losses as-
sociated with a comprehensive set of diseases [31] and
represents the best available standard of evidence on
health needs, but does require rich data.
BIAs can be relatively cheap to perform [32], are adaptable
to the available data and can provide an informative picture
of inequalities over time if they are conducted intermittently.
However, they do not provide evidence on whether add-
itional expenditure is likely to improve health inequalities.
Increases in expenditure could conceivably go to funding
services that are utilised by higher income groups, generating
more inequality. In such cases, equity objectives could be
pursued by alternative means, such as addressing the social
determinants of health inequality or targeting funding
toward inequality-improving interventions.
Marginal benefit incidence analysis
Marginal benefit incidence analysis (MBIA) has been
proposed to answer the question of which groups benefit
from additional expenditure [33, 34]. MBIA estimates
the statistical relationship between benefit incidence (for
each social group) and public health expenditures, by
comparing the levels of each over time across regions or
at a single point in time between regions. As a result, it
produces estimates of the expected distribution of bene-
fits that result from increases in expenditure (or alterna-
tively, the ‘losses’ from decreases in expenditure). In an
analysis of marginal benefits in Indonesia, Kruse and
others find that increases in public health care
expenditures benefited the low income groups more
substantially than a static analysis would suggest; the
bottom quartile received 23% of the benefits in the trad-
itional BIA versus 25% in the MBIA [35]. Conversely the
shares of the richest quartile dropped from 24% in the
BIA to 21% in the MBIA.
MBIA was developed with a view to examining benefit
incidence across the public sector at the margin, although
few applications have been made in the health sector. The
causes for this low uptake are likely to include greater data
requirements and more complicated estimation proce-
dures relative to BIAs. MBIAs require (i) relatively detailed
information on public health care expenditures (either
over time or across a large number of regions) and (ii)
knowledge of appropriate statistical methods to conduct
the analysis. The latter is particularly important to avoid
biases that can occur when estimating a causal relation-
ship between health behaviours and public expenditure.
Reverse causality, for example, is a major concern, as
higher health expenditure may be historically allocated in
response to poor healthcare outcomes, including utilisa-
tion. Not mitigating for these potential biases would there-
fore produce inaccurate results. A full discussion of these
issues can be found in Gravelle and Backhouse [36]; for an
applied example that uses instrumental variable regression
to address these issues, see Lomas and others [37].
Can government health expenditure more
effectively promote equity?
Regional funding formulae
A substantial proportion of countries now fund health
care using a national public budget. Whether this is
funded almost entirely through general taxation or na-
tional health insurance scheme or from a combination
of public and donor funds, a growing number distribute
this budget to decentralised, regional purchasing bodies
[38, 39]. The use of mathematical formulae to help allo-
cate the budget originated in the UK in the late 1970s
[40] and they are now a feature of health systems in
LMICs, particularly in Africa [41–43] and South Amer-
ica [44]. Overviews of the formulae adopted by three Af-
rican countries is provided in Table 1.
One of the central justifications for implementing a re-
source allocation formula is the promotion of both vertical
and horizontal equity: regions with the same health needs
are provided with the same resources (horizontal), and
regions with different health needs are provided with dif-
ferent resources (vertical). Without formulae, regional
budget allocations are based on historical precedent, a
phenomenon referred to by Maynard & Ludbrook as
“what you got last year, plus an allowance for growth, plus
an allowance for scandal” [50]. Furthermore, budgets may
also be influenced by favouritism or political importance.
By distributing resources in accordance to the health-care
needs of the local population, allocation formulae can
overcome these issues.
The formulae allocate resources based on the health
needs of each geographical area. Many formulae define
need in terms of the historical levels of met needs,
expressed in terms of health care utilisation [39]. Utilisa-
tion for an area is predicted by analysing historical data
on health care use. Where utilisation is expected to be
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higher, a region’s population size will be reweighted to
increase their share of resources. An example of this
process, from the original English 1976 formula, is
shown in Table 2, and a step-by-step guide to estimating
and implementing allocation formulae can be found in
Mcintyre and Anselmi [38]. It has been recommended
that the implementation of formulae allocations should
be slowly adjusted from existing levels to the formulae-
derived target allocation, so that supply factors can ad-
just and any potential political ramifications of cutting
allocations can be minimised [51].
Formulae can also attempt to account for historically
unmet needs that might have prevented individuals from
seeking care. Early attempts used relatively unsophisti-
cated area-level mortality statistics, data that are becoming
more widely available in LMICs. However, the quality of
administrative data should be used with care if there is
suspected underreporting. For example, if mortality is
underreported in those districts where it is highest, areas
with greater needs will not receive adequate allocations.
Financial incentives can be utilised to improve data collec-
tion at subnational levels, although these should be care-
fully designed to limit unintended consequences [52].
The proportion of total healthcare expenditure that is fi-
nanced through tax-funded public resources in LMICs is
typically smaller than is seen in high-income countries. For
example, analyses in Kenya and Zambia found that the re-
spective resource allocation formulae accounted for 10 and
25% of the total health expenditures only [41, 48], com-
pared with over 60% for the National Health Service in
Table 1 Overview of three resource allocation formulae in
Africa
Country Year
initiated
Description
Malawi 2000 Applies to recurrent, operational health
expenditures only. Following a revision in 2008,
the budget has been allocated to 28 districts
based on a weighted population calculation
determined by four factors: outpatient department
utilisation, bed capacity, district cost level and the
prevalence of stunting (45). The weights attached
to each factor are set by health policymakers. Set
to be revised in future and will explore ways to
align district allocations with the delivery of the
Essential Health Package, Malawi’s defined health
benefits package (46).
Tanzania 2004 Applied to a pool of donor funds under the
‘Sector Wide Approach’ initiative. Reweights the
regional population according to three factors: a
mileage index to account for supply costs; under-5
mortality rates as a measure of overall need and
the local poverty level to reflect socioeconomic
factors. (47). A major part of Tanzanian healthcare
funding was reported to stem from ‘block’ grants
allocated to regions for multiple public services,
and therefore reflected a range of other regional
needs besides healthcare.
Zambia 1994 Population-based formula was revised in both
2004 and 2010 to include socioeconomic and
geographical factors, respectively (48). Although
comparisons between the allocations derived from
the formula and actual expenditure have shown
large discrepancies, gradual progress toward the
‘equity target’ allocations is being made (49).
Table 2 Need-weighted populations used in the resource allocation formula for English regions in 1976. A positive difference
between the crude and weighted population indicates that health care needs are higher than average and the region requires a
greater share of resources
Region Crude population (000’s) Weighted population (000’s) Difference (%)
Northern 3173 3276 3%
Yorkshire 3576 3750 5%
Trent 4661 4594 -1%
East Anglian 1898 1817 −4%
NW Thames 3584 3422 −5%
NE Thames 3874 3757 −3%
SE Thames 3748 3815 2%
SW Thames 2918 3068 5%
Wessex 2816 2773 −2%
Oxford 2403 2118 −12%
South Western 3250 3185 −2%
West Midlands 5342 5153 −4%
Mersey 2543 2655 4%
North Western 4146 4549 10%
Source: Department of Health and Social Security (1976)
Notes: The factors for weighting included age, sex, standardized mortality and hospital bed utilisation
NW North west, NE North east, SE South east, SW South west
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England. The use of ‘basket funds’ that pool donor funding
with government budgets are an important tool to increase
the equitability of funding across the system. However,
pooling frameworks like Sector Wide Approaches [53] can
be politically challenging to negotiate, as donors may have a
different set of objectives and may wish to allocate re-
sources differently. For example, some donor organisations
focus on specific diseases, and allocate their funding to in-
frastructure and treatments independently of existing
health system infrastructure.
Whichever method is used, area-level resource alloca-
tion should also attempt to account for differences in
healthcare supply between areas, which are likely to be
more common and substantial in LMIC settings. This
could involve including supply variables (such as mean
distance to a hospital or waiting time) in the allocation
formula. Gap analyses of regional health system capacity
can also be conducted to give an indication of the capital
resources required to improve human resources and
healthcare facilities to a sufficient level [38].
Health benefits packages
The increasing popularity of explicitly defined health
benefits packages (HBPs) in resource-constrained set-
tings [54] offers an alternative method to traditional for-
mulae when defining area-level allocations. HBPs detail
which healthcare services are to be funded from a set of
health resources, can therefore provide a way to estimate
health resource needs by linking the costs of providing
services with the expected target patient population.
Work in Malawi has shown that this can result in sub-
stantially different allocations from previous formula-based
methods [46]. Disease incidence and prevalence, calculated
from household survey data, provided estimates of disease-
specific patient populations for each district in Malawi.
These were then combined with the costs of providing
interventions, which had been previously detailed in an eco-
nomic analysis of the HBP [55]. Allocation changes of over
50% were recommended for four of Malawi’s 28 districts.
Differences in the supply of and access to health services
between districts can be explored by comparing an idealis-
tic, fully covered target population and a more realistic, ex-
pected level of population coverage.
Health system reforms
Planners in the health sector may also pursue equity
goals through the design of the health system, whether
this be through financing mechanisms or the organisa-
tion of health services. Typically, the objective of
introducing these types of reforms will be to increase
access to healthcare or provide financial protection to
citizens. These types of activities include introducing
community-based or social health insurance schemes
[56] or investing in primary care initiatives such as com-
munity health worker programmes [57].
Health system reforms, insofar as they have an
implementation cost and affect healthcare utilisation and
health outcomes, are conceptually akin to highly complex
interventions that can be evaluated using the economic
evaluation methods outlined in the following section. The
most appropriate analysis to undertake will be dependent
upon the equity objectives behind the policy [58].
Which interventions provide the best value for
money in reducing inequality?
As well as allocating health resources more equitably,
decision makers may similarly care that those resources
are spent equitably. This can be achieved by analysing
how specific interventions and policies are likely to affect
inequalities. A number of tools from the economic
evaluation literature can provide quantitative evidence
on the comparative impacts of interventions on inequal-
ities and population health.
The prevailing approach to the economic evaluation of
health interventions is the use of cost-effectiveness ana-
lysis. This framework compares the benefits (expressed
in terms of health gain) with the opportunity costs
(expressed in terms of the health lost from not funding
other interventions) for the average patient. In this sec-
tion we discuss two prominent alternative approaches
that go beyond the average patient to consider impacts
across a range of equity-relevant subgroups: extended
cost-effectiveness analysis (ECEA) and distributional
cost-effectiveness analysis (DCEA). Directly applying
weights to health benefits and opportunity costs accord-
ing to the characteristics of the recipients provides a
third alternative [59], although this is yet to be applied
in practice and presents a range of practical and meth-
odological issues [60].
DCEA and ECEA both augment the mathematical mod-
elling process of traditional cost-effectiveness analysis to
estimate the distribution of impacts of an intervention.
Differences in health benefits can be function of differ-
ences in underlying health (e.g. morbidities), health-
seeking behaviour and expected utilisation. In addition to
health outcomes and costs, ECEA also models criteria
highly relevant to LMICs settings: financial protection
from catastrophic payments and the private expenditures
averted from providing the intervention on the public
budget [61]. Rather than combine the various criteria,
ECEAs present a range of disaggregated outcomes, such
as those shown in Fig. 3.
DCEA utilises only two criteria: (i) the total health im-
pact of an intervention and (ii) it effects on health inequal-
ities [63]. Health inequality is modelled prior to an
intervention, and the impact of the intervention is mod-
elled to generate a hypothetical ‘post-intervention’
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distribution. Although a full DCEA approach uses bespoke
estimates of health benefits and costs from a mathematical
model, an aggregate, less data intensive approach has also
been developed that allocates health benefits to equity-
relevant groups based on their share of healthcare utilisa-
tion or disease prevalence [64, 65]. Health-related social
welfare indices are then applied to evaluate the changes in
total health and health inequality in instances where a
trade-off occurs (i.e. interventions that improve popula-
tion health and increase inequality and vice versa).
There are many applications of ECEA in LMICs in Asia,
the Middle East and Africa. A wide range of health inter-
ventions have been analysed, including neonatal care [66],
tuberculosis treatment [67] and rotavirus vaccination [68].
Early applications of DCEA have been limited to high-
income countries [69], although an analysis of rotavirus
vaccination has also been developed for Ethiopia [70].
Discussion
Health equity is a complex topic that deals with questions
of social value as well as fact [12]. Inequalities related to
the health sector can usually be found however one
chooses to stratify a population, whether that be by age,
sex, income, ethnicity or another characteristic [71]. The
methods discussed in this paper can be applied to what-
ever set of characteristics are relevant to a society and can
be used to help inform a range of health resource alloca-
tion decisions. BIA can give a broad picture of inequality
and can be conducted using commonly available data on
healthcare utilisation and expenditure. An MBIA can in-
form decisions about the impact of changing expenditure
but requires additional data and statistical expertise. In
terms of evaluating policies and interventions, DCEAs
provide the thorough estimation of health inequality im-
pacts, and ECEA can provide information across a range
of outcomes – commonly financial risk protection and
health. The evidence produced by ECEAs and DCEAs can
feed into the deliberative processes used by health policy-
makers to allocate health resources. Incorporating them
into structured processes such as health equity impact
assessments [72] is also feasible.
Needs-based resource allocation formulae also form a
central policy tool for promoting health equity. As these
have been widely implemented (with differing degrees of
sophistication) across the world, the principal technical
challenge is to collect and utilise better data that will
provide more accurate indicators on healthcare needs.
The other main challenges are largely political: (i) to
bring a greater proportion of total healthcare expend-
iture under the purview of the formulae through the cre-
ation of donor funding pools and (ii) to reduce political
pressure and interference. The latter could be achieved
by engaging with stakeholders to increase support for
the formulae [72] and explicitly setting intermediate an-
nual targets that bridge current and target allocations.
Different combinations of the methods presented can
be utilised depending on the type of equity objective that
is being pursued. When this is increasing access to
healthcare, BIA can be used to assess the extent to
which utilisation differs from need, whilst a resource al-
location formula can direct resources to where need is
greatest. Alternatively, if the objective is to reduce unfair
health outcomes, then a resource allocation formula can
give extra weight to associated factors such as socioeco-
nomic deprivation [51], whilst DCEAs can identify the
interventions that best reduce disparities. ECEA can
similarly be utilised to assess impacts on financial pro-
tection and poverty; key indicators for systems working
towards universal health coverage [73].
The choice of which inequality measures to adopt will
depend upon the availability of data and the decision-
making context. Simple gap statistics and the slope
index of inequality can be simpler to compute and are
more easily interpretable by a non-technical audience.
Fig. 3 Extended cost-effectiveness results by wealth quintile of a salt reduction policy in South Africa. Source: Watkins et al. [62]
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However, by assuming a linear relationship between the
health outcome and the equity characteristic (slope
index) or ignoring data in the middle of the distribution
(gaps), these measures can produce misleading estimates
of the level of inequality. Many of the methods discussed
in this paper, from BIA to DCEA, evaluate inequalities
using more technically complex measures such concen-
tration index or health-related social welfare indices.
A critical challenge common to all types of health equity
analysis in LMICs is the availability of data. Inconsistent
or entirely absent administrative data or vital statistics col-
lection processes, particularly in the poorest countries,
represents a major obstacle to conducting robust research.
To compound matters, the incentives for improving data
collection may be prohibitively costly for the countries’
most in need of them. Regional or country specific health
surveys, such as the Demographic and Health Surveys
program [74], can also be used to obtain the distribution
of a range of health and health service indicators. The
Box 1 Benefit incidence analysis case study: Malawi
Mangham [24] conducted a benefit incidence analysis (BIA) of
government curative health services in Malawi using data from
2004 to 5. Expenditure data was acquired directly from
Malawian national health accounts, whilst utilisation was
estimated from the Second Integrated Household Survey from
2004 to 5. The latter provided (i) the proportion reporting ill in
the 2 weeks prior to interview and (ii) how many received
treatment at government health facilities. The two-week rates
are scaled up estimate annual utilisation.
Total expenditure was available for two types of facility for each
of 28 districts: health centre and hospital. Total expenditure was
divided by total utilisation for both types of facility to obtain an
estimate of the government subsidy per unit of utilisation. This
was then multiplied by the amount of utilisation in five, equally
sized socioeconomic group to obtain the distribution of benefit.
The lowest socioeconomic group had a proportionately smaller
share of benefits: despite representing 20% of the population,
their share of benefits was 15.8%. The three highest groups
reported shares of 21.2 to 21.5%. The author notes that the
observed inequality is lower than in other African countries,
citing the presence of the defined national health benefits
package and the absence of user fees as potential causes for
this relative success.
Socioeconomic group
Facility 1 (lowest) 2 (highest) 3 4 5
Hospital 14% 17.8% 20.9% 22.3% 24.9%
Health centre 18.2% 22.7% 18% 26.1% 15%
Overall 15.8% 20.2% 21.3% 21.5% 21.2%
The analysis highlights several common issues with conducting
BIAs. The lower reported rates of illness and utilisation amongst
the poorest are counter-intuitive to expectations about health
needs and are attributed to a higher tolerance of illness in lower
socioeconomic groups. A potential consequence of this is that if
low income patients are presenting with more serious illnesses,
a unit of healthcare utilisation is likely to be more expensive, vio-
lating the assumption that each unit is associated with the same
subsidy. Furthermore, the scaling up of the two-week utilisation
rates to annual figures does not adjust for the time of year of
the survey, which may lead to under- or over-reporting due to
seasonal variations.
Box 2 Extended cost-effectiveness analysis of rotavirus
vaccination in Ethiopia
Pecenka and colleagues used an extended cost-effectiveness ap-
proach to evaluate universal public financing of prevention strat-
egies and treatment of diarrhoea in Ethiopia [77]. Two strategies
were compared: diarrhoea treatment and rotavirus vaccination
plus diarrhoea treatment. They measured three outcomes across
five, equally-sized wealth quintile groups: deaths averted, house-
hold expenditures averted and government expenditures
averted.
Over 10 separate studies are used to build a mathematical
model simulating a cohort of children aged 0 to 5. The authors
use data that reflects how healthcare resource use and rotavirus
mortality differs by income group, and estimate how the costs
are shared between the government and private households
under each scenario.
Their results show that combining treatment of diarrhoea with
rotavirus vaccination averts an additional 1200 deaths and $1.5
million in private household expenditure, as well as saving $7
million of government expenditures. The health gains accrue
mostly to the poorest wealth quintile, as they experience the
highest levels of mortality from diarrhoea. Since private
expenditures were highest in the wealthiest groups, averted
household expenditures are lowest for the poorest.
A key aspect missing from this and other applications of
extended cost-effectiveness analysis is opportunity cost. The re-
sources being used to fund the public finance of vaccination
and treatment could have been otherwise employed on other
interventions or social programs, which may also have averted
deaths and private household expenditures. Only when this is
accounted for can an informative estimate of the value of the
interventions be properly understood.
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World Bank Health Equity and Financial Protection Indi-
cators (HEFPI) dataset, which compiles data from over 40
health surveys, provides a useful starting point for apply-
ing many of the methods outlined in this paper.
The incorporation of equity concerns in the design
and implementation of HBPs is an emerging consider-
ation in LMICs. A review of 13 packages in Africa noted
that, although equity was a key motivation behind the
design of the package, evidence-based methods for con-
sidering the equity impacts of the included interventions
was inconsistent [75]. The economic evaluation ap-
proaches we have described can be used to inform the
design of future HBPs. Similarly, resource allocation for-
mulae techniques may useful in equitably allocating re-
gional health budgets so that local budget holders hold
sufficient resources to provide the local populace with
the interventions in the HBP [46].
The focus of this article has been on the effects of health
sector decisions on within-country inequalities. Many of
the methods have scope, however, to be adapted to investi-
gate between-country differences and resource allocation
outside of the health sector. For example, investment deci-
sions by international donor organizations or government
departments responsible for overseas aid could evaluate po-
tential investments in terms of how they affected global in-
equalities in healthcare access and utilisation, whilst
policies in education or taxation can be evaluated in terms
of their health consequences [76].
Our review does not represent a comprehensive overview
of health equity measurement and assessment. We have con-
centrated on those methods most commonly applied and
our literature searches were necessarily pragmatic given the
breadth of literature on health equity and resource allocation.
We have presented the use of methods in the context of a
single, authorised decision-maker, and have not covered their
role in more complex decision-making contexts of multiple
actors with differing authority and objectives.
Conclusion
This paper is intended to provide an overview of the
methods available to assess and address health equity. We
have described the intuitions underlying the approaches
and what types of equity questions they address. More
than ever, healthcare decision makers can now utilise
quantitative analysis to generate evidence to support their
pursuit of this important social objective.
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